Explore our flagship enterprise products backed by robust quality systems and worldwide export capabilities.
In the rapidly evolving global pharmaceutical landscape, securing high-purity Active Pharmaceutical Ingredients (APIs) with robust supply chain security is a strategic imperative. Bepotastine Besilate (CAS Number: 190786-44-8 / 125602-71-5) represents a benchmark second-generation selective histamine H1 receptor antagonist and mast cell stabilizer. As pharmaceutical formulation leaders, contract development and manufacturing organizations (CDMOs), and global procurement executives seek reliable wholesale factories, navigating chemical synthesis quality, polymorph consistency, and regulatory dossiers is crucial.
Bepotastine Besilate suppresses histamine H1-receptor-mediated allergic reactions while simultaneously inhibiting mast cell degranulation and leukocyte migration into inflamed ocular and cutaneous tissue. This dual mechanism offers superior therapeutic relief in ophthalmic drops and oral anti-allergic formulations.
Our specialized wholesale manufacturing facilities synthesize Bepotastine Besilate achieving assay purity levels exceeding 99.5%. Organic impurities—including the S-enantiomer, pyridinyl degradation products, and residual alkylating agents—are strictly controlled well below ICH Q3A guidelines.
Controlled crystallization protocols ensure batch-to-batch polymorphic uniformity (Form I crystal matrix). This guarantees optimized solubility profiles in ophthalmic solution formulation (0.5% w/v) and uniform dissolution rate in oral solid dosage manufacturing.
Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions for intermediate synthesis and industrial-scale chemical production.
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
End-to-end technical consultation, analytical method development, setup of high-throughput peptide labs, and full support for scale-up optimization of small molecule active ingredients.
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
Navigating the next generation of ocular anti-allergy and dermatological therapies requires continuous improvement in chemical synthesis technology, catalytic efficiency, and green chemistry metrics.
The chemical structure of Bepotastine, (S)-4-[4-(4-chlorophenyl)(2-pyridyl)methoxy]piperidino]butyric acid monobenzenesulfonate, contains an asymmetric stereocenter. Traditional routes relied on resolution via dibenzoyl-L-tartaric acid. Our forward-looking synthesis roadmap incorporates asymmetric enzymatic reduction and chiral organocatalysts, reducing chiral impurity carryover to less than 0.05% while elevating atom economy by 35% across manufacturing batches.
With increasing clinical focus on dry eye disease (DED) exacerbated by traditional preservatives like Benzalkonium Chloride (BAC), research facilities are utilizing high-purity wholesale Bepotastine Besilate for single-dose preservative-free (SDPF) ocular formulations. The physical stability, low ionic binding, and low heavy metal impurity profile (< 5 ppm) of our API prevent degradation during micro-sterilization and unit-dose packaging operations.
| Analytical Test Parameter | Acceptance Criteria / Standard | Methodology |
|---|---|---|
| Chemical Appearance | White to off-white crystalline powder | Visual Inspection |
| Identification (IR, HPLC) | Conforms to Reference Standard spectra | FT-IR Spectroscopy / HPLC Retention Time |
| Assay (Drying Basis) | 98.5% – 101.5% | HPLC Assay (Reverse Phase) |
| Enantiomeric Purity (R-isomer) | ≤ 0.10% | Chiral HPLC Analysis |
| Related Organic Impurities | Individual Impurity ≤ 0.10%; Total Impurities ≤ 0.50% | UHPLC-UV / LC-MS |
| Residual Solvents | Meets ICH Q3C limits (Methanol, Toluene, IPA) | Headspace Gas Chromatography (GC-FID) |
| Heavy Metals & Ash | Heavy Metals ≤ 10 ppm; Residue on Ignition ≤ 0.10% | ICP-MS / Gravimetric Ignition |
To mitigate global pharmaceutical supply disruptions, modern chemical facilities in China are undergoing complete digital transformations. By leveraging Industry 4.0 architecture, factory units optimize output without sacrificing quality parameters.
Moving from classical batch reactors to continuous micro-channel reactors for critical alkylation and salt-formation steps. This continuous process enhances thermal control, reduces side-product formation, and increases single-line annual yield to metric-ton scale seamlessly.
By standardizing early-stage intermediate sourcing (such as 4-chlorophenyl-2-pyridylmethanol) in-house within our 250,000 m² construction footprint, our production facilities eliminate third-party markup risks and shield buyers from upstream raw material price volatility.
In-line NIR and Raman spectroscopy monitor reaction kinetics in real-time. Any deviation in temperature, reagent stoichiometry, or moisture levels triggers automated system adjustments, guaranteeing zero off-spec batches.
Enterprise purchasers faced with regulatory audits, regional health authority approvals, and tight product launch timelines require robust supplier partnerships rather than transactional transactional purchasing.
Commercialization of finished dosage forms (FDF) requires complete raw material documentation. We provide comprehensive Drug Master Files (DMF), Certificates of Analysis (CoA), Stability Data under ICH climates (Zone II & IVb), and TSE/BSE risk assessment certificates to streamline customer submission to regulatory bodies such as US FDA, EMA, NMPA, and PMDA.
Beyond bulk API supply, our infrastructure handles custom synthesis of specialized derivatives, formulation optimization, and lab setup services. Through flexible licensing models, partners can fast-track generic or hybrid FDF launches in emerging markets.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa.
Local teams ensure seamless communication, rapid customs clearance, local warehouse stocking, and real-time technical consultation across Latin America and African markets.
Our collaborative production lines operate under strict cGMP principles, adhering to ICH guidelines for quality risk management (Q9) and pharmaceutical quality systems (Q10).
Offering tiered procurement packages ranging from R&D kilogram-scale samples for pre-clinical evaluation to multi-ton commercial quantities delivered under DDP/CIF incoterms.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa. Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
View Details
Explore our latest technical research papers, product launch insights, and pharmaceutical manufacturing updates.
Introduction to Selank Acetate API Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient (API) composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Originally developed through neuropharmacological research, Selank is a derivative of the endogenous...
Trusted Thymosin Beta-4 API Manufacturer and Global Peptide Supplier As a professional Thymosin Beta-4 API manufacturer and supplier, we provide high-quality Thymosin Beta-4 peptide API solutions for biotechnology companies, pharmaceutical research organizations, and li...
Introduction BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its potential biological activities related to tissue repair, gastrointestinal protection, angiogenesis, and inflammatory regulation. As a peptide ac...
With the continuous development of neuroscience, peptide technology, and life science research, neuroactive peptides have become an important area of scientific investigation. Semax, a synthetic peptide derived from an ACTH fragment, has attracted attention among researchers due to its unique mol...
SS-31 API, also known as Elamipretide, MTP-131, Bendavia, and SS31, is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane. By stabilizing mitochondrial structure and supporting cellular bioenergetics, SS-31 ha...
Direct answers to high-intent regulatory, synthesis, and logistical inquiries regarding Bepotastine Besilate manufacturing.
Explore our extended peptide and small-molecule commercial offerings available for global dispatch.
China 30mg 99% Purity Semaglutide Weight Loss Peptide Fitness Injection Peptides Manufacturers, Companies
View Details
Buy Tirzepatide Powder for Injection for Weight Loss 30mg Per Vial Purity 99% Product, Products
View Details
